Jonathan G. Drachman, President and CEO at Neoleukin Therapeutics, Inc. (NLTX), bought 125,000 shares at $6.45 ($772K) on 2021-08-25, disclosed to the SEC on 2021-08-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.11 | 100,000 | $611K | 79.1% |
| 2 | $6.45 | 25,000 | $161K | 20.9% |
| Total | $6.18 avg | 125,000 | $772K | 100% |
| Filing → |
| NLTX | BUY | 2019-12-20 | $2.0M | — | Filing → |
| NLTX | BUY | 2019-09-11 | $1.6M | — | Filing → |
| SGEN | SELL | 2018-03-07 | $725K | — | Filing → |